10.1007/s00392-023-02254-9 45
Quantification indicated that in tumor-bearing WT mice, host-derived, TME-derived, tumor-derived, and ovary-derived CXCL10 accounted for 38.16%, 32.4%, 23.8%, and 5.93% of total plasma CXCL10, respectively (Fig
When semaglutide, tirzepatide, and other GLP-1 receptor agonists cause fluid and electrolyte losses through gastrointestinal side effects, or when reduced food intake limits your natural electrolyte consumption and/or water intake via food, your gut function can suffer
While rapid fat loss is a sign of treatment success, the unintended consequence of facial aging can pose emotional and aesthetic challenges for patients
Many counterfeit GLP-1 products have been found to contain dangerously high levels of active ingredients or none at all